MAXRELIEF
LIVE

Serial Number

88283832

Owner

MaxRelief USA, Inc.

Attorney

Andrew J Levison

First Use Date

Jan 1, 2012

Filing Date

Jan 31, 2019

Add to watchlist:

No watchlists yet
View on USPTO

MAXRELIEF Trademark

Serial Number: 88283832 • Registration: 6110575

MAXRELIEF is a trademark filed by MaxRelief USA, Inc. on January 31, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

MaxRelief USA, Inc. (3 trademarks)

3053 Fillmore St, Suite 123
San Francisco, CA 94123

Entity Type: 03

Trademark Details

Filing Date

January 31, 2019

Registration Date

July 28, 2020

First Use Anywhere

January 1, 2012

First Use in Commerce

January 1, 2012

Published for Opposition

May 12, 2020

Goods & Services

Pain relief cream and spray in the nature of pain relief medication and topical analgesic creams

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 28, 2025 REM1
NOTICE OF SUIT
Oct 21, 2021 NOSU
NOTICE OF SUIT
Oct 5, 2021 NOSU
REGISTERED-PRINCIPAL REGISTER
Jul 28, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2020 CNSA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 28, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 28, 2019 GNSL
SUSPENSION LETTER WRITTEN
Oct 28, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 1, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 1, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2019 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 15, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 15, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 15, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 13, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2019 NWOS
NEW APPLICATION ENTERED
Feb 4, 2019 NWAP